Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer (Q56815464)
article by Paal F. Brunsvig et al published 21 February 2006 in Cancer Immunology, Immunotherapy
Language:
Current Data About Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
(P31) (Q13442814)

(P50) (Q5621121)
(P1545) 11
(P1932) Gustav Gaudernack

(Q91362816)
(P1545) 4
(P1932) Gunnar Kvalheim

(P304) 1553-1564

(P433) 12

(P478) 55

(P577) Tuesday, February 21, 2006

(P921) (Q181600)

(Q3658562)
(P887)

(P1433) (Q5031409)

(P1476) "Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer" (language: en)

(P2093) Paal F. Brunsvig
(P1545) 1

Steinar Aamdal
(P1545) 2

Marianne K. Gjertsen
(P1545) 3

Carrie J. Markowski-Grimsrud
(P1545) 5

Ingunn Sve
(P1545) 6

Marianne Dyrhaug
(P1545) 7

Sissel Trachsel
(P1545) 8

Mona Møller
(P1545) 9

Jon A. Eriksen
(P1545) 10

other details
description article by Paal F. Brunsvig et al published 21 February 2006 in Cancer Immunology, Immunotherapy

External Links
(P356) 10.1007/S00262-006-0145-7
(P698) 16491401